Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1482-1491

  Yun, T J ^a   Tallquist, M D ^a   Aicher, A ^a   Rafferty, K L ^a   Marshall, A J ^a   Moon, J J ^a   Ewings, M K ^a   Mohaupt, M ^a   Herring, S W ^a   Clark, E A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN G3; INTERLEUKIN 7; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BONE METABOLISM; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION;

EID: 0035253693     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1482     Document Type: Article

References (46)

1. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
2. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
3. Apoptosis control by death and decoy receptors
4. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
5. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
6. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
7. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
8. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
9. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
10. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
11. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
12. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
13. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
14. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
15. To die or not to die - The quest of the TRAIL receptors
16. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
17. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies
18. RANK is essential for osteoclast and lymph node development
19. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells
20. TRANCE (tumor necrosis factor (TNF)-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
21. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
22. How B and T cells talk to each other
23. Immune regulation by CD40 and its ligand GP39
24. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
25. The PDGFα receptor is required for neural crest cell development and for normal patterning of the somites
26. Tetracycline fluorescence incident photometry: A new technique to quantitate bone formation
27. CD22 regulates thymus-independent responses and the lifespan of B cells
28. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression
29. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
30. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice
31. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides
32. Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis
33. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
34. Stimulation of B-cell progenitors by cloned murine interleukin-7
35. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
36. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
37. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk
38. TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation
39. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
40. Good hope for making osteoporosis a disease of the past
41. Sex hormones as negative regulators of lymphopoiesis
42. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture
43. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
44. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors
45. Transitional B cells are the target of negative selection in the B cell compartment
46. Signaling thresholds and interclonal competition in preimmune B-cell selection